China SXT Pharmaceuticals Inc

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, China SXT Pharmaceuticals Inc had 18.10M in cash and cash equivalents.

China SXT Pharmaceuticals Inc reported 6.22M in total liabilities as of the latest reported quarter, including 6.01M in current liabilities and 211.68K in non-current liabilities.

As of the latest reported quarter, China SXT Pharmaceuticals Inc's total assets were 34.75M, consisting of 34.51M in current assets and 244.85K in non-current assets.

China SXT Pharmaceuticals Inc reported 29.71M in total shareholders' equity as of the latest reported quarter.